VC Firm 11.2 Capital Raises $101 Million To Back More ‘Deep Tech’ Companies Like Ginkgo Bioworks And Hinge Health

Las Vegas-based Shelley Zhuang was an early investor in Cruise, Ginkgo Bioworks and Hinge Health. Now she has $101,010,101 for a second "deep tech" fund.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Science /science Money /money Investing /investing Editors' Pick editors-pick technology Source Type: news